Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04473469 · ClinicalTrials.gov registry record · NA
Previously Implanted Pudendal Nerve Stimulation
A NA study, sponsored by University of Michigan.
- Completed
- Registry status
- NA
- Development phase
- 5
- Enrollment target
NCT04473469: Completed NA study, sponsored by University of Michigan.
NCT04473469 is a NA study that has completed, run by University of Michigan. The registered enrollment target is 5 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04473469, a NA study, has completed, sponsored by University of Michigan.
- COMPLETED
- Registry status
- NA
- Development phase
- 5 participants
- Enrollment target
Study Summary
This study seeks to examine the response of the bladder to different pudendal nerve stimulation frequencies, by studying patients who have been previously-implanted with pudendal nerve neurostimulators.
Primary Outcome
The results reflects the number of participants who experienced an evoked bladder contraction of at least 20 centimeters of water during stimulation of the pudendal nerve. Bladder contractions were evoked by applying nerve stimulation to the pudendal nerve through testing of the participant's implanted stimulator.
Interventions
- DEVICE Medtronic Interstim II Model 3058 Neurostimulator
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5 participants |
| Start Date | 2021-01-19 |
| Est. Completion | 2023-05-02 |
| Phase | NA |
What the finished NCT04473469 record still lists
NCT04473469 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 5 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 1 intervention - of which Medtronic Interstim II Model 3058 Neurostimulator is the first listed.
NCT04473469 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04473469 about?
NCT04473469 is a clinical study titled "Previously Implanted Pudendal Nerve Stimulation". This study seeks to examine the response of the bladder to different pudendal nerve stimulation frequencies, by studying patients who have been previously-implanted with pudendal nerve neurostimulators.
What is the current status of trial NCT04473469?
This trial is currently completed. It is a NA study. The enrollment target is 5 participants. The study started on 2021-01-19. Estimated completion is 2023-05-02.
What interventions are being tested in trial NCT04473469?
The interventions under investigation include: Medtronic Interstim II Model 3058 Neurostimulator (DEVICE).
Who is sponsoring clinical trial NCT04473469?
This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04473469's enrollment target sits among peer trials
5 1988th of 2000 higher than 5 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI